Alterations in pharmacogenetic genes and their implications for imatinib resistance in Chronic Myeloid Leukemia patients from an admixed population
Cancer Chemotherapy and Pharmacology · 2024
DOI: 10.1007/s00280-024-04689-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2024. Verfasst von Karla Beatriz Cardias Cereja-Pantoja und 15 weiteren Autor:innen. Beteiligte Einrichtung: Núcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, PA, 66073-005, Brazil. Hauptthemen laut MEDLINE: Imatinib Mesylate, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Drug Resistance, Neoplasm, Protein Kinase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Pró-Reitoria de Pesquisa e Pós-Graduação, Universidade Federal do Pará.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Núcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, PA, 66073-005, Brazil.
- Ophir Loyola Hospital, Belém, PA, 66063-240, Brazil.
- Núcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, PA, 66073-005, Brazil. francisco.cezar2205@gmail.com.
- Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas - CiMUS, Universidad de Santiago de Compostela, Santiago de Compostela, 15782, Spain.
ORCID-Profile: Francisco Cezar Aquino de Moraes
Förderung
- Pró-Reitoria de Pesquisa e Pós-Graduação, Universidade Federal do Pará
Zitieren
APA
Cereja-Pantoja, K. B. C., de Brito Azevedo, T. C., Vinagre, L. W. M. S., de Moraes, F. C. A., da Costa Nunes, G. G., Monte, N., de Alcântara, A. L., Cohen-Paes, A., Fernandes, M. R., Batista Dos Santos, S. E., de Assumpção, P. P., Ribeiro Dos Santos, Â. K., Burbano, R. M. R., Guerrero, R. C., Carracedo, Á., & Carneiro Dos Santos, N. P. (2024). Alterations in pharmacogenetic genes and their implications for imatinib resistance in Chronic Myeloid Leukemia patients from an admixed population. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04689-x
Vancouver
Cereja-Pantoja KBC, de Brito Azevedo TC, Vinagre LWMS, de Moraes FCA, da Costa Nunes GG, Monte N, et al. Alterations in pharmacogenetic genes and their implications for imatinib resistance in Chronic Myeloid Leukemia patients from an admixed population. Cancer Chemotherapy and Pharmacology. 2024. doi:10.1007/s00280-024-04689-x
BibTeX
@article{CerejaPantoja2024,
author = {Cereja-Pantoja, Karla Beatriz Cardias and de Brito Azevedo, Tereza Cristina and Vinagre, Lui Wallacy Morikawa Souza and de Moraes, Francisco Cezar Aquino and da Costa Nunes, Giovanna Gilioli and Monte, Natasha and de Alcântara, Angélica Leite and Cohen-Paes, Amanda and Fernandes, Marianne Rodrigues and Batista Dos Santos, Sidney Emanuel and de Assumpção, Paulo Pimentel and Ribeiro Dos Santos, Ândrea Kely and Burbano, Rommel Mario Rodríguez and Guerrero, Raquel Cruz and Carracedo, Ángel and Carneiro Dos Santos, Ney Pereira},
title = {Alterations in pharmacogenetic genes and their implications for imatinib resistance in Chronic Myeloid Leukemia patients from an admixed population},
journal = {Cancer Chemotherapy and Pharmacology},
year = {2024},
doi = {10.1007/s00280-024-04689-x}
}
EUVIMED